Source:http://linkedlifedata.com/resource/pubmed/id/12121347
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-7-17
|
| pubmed:abstractText |
Patients with homozygous familial hypercholesterolaemia (FH) caused by receptor-negative, low-density lipoprotein (LDL) receptor gene mutations have higher concentrations of LDL-cholesterol in plasma and earlier onset of cardiovascular disease (CVD) than patients homozygous for receptor-defective, LDL receptor mutations. In contrast, it is uncertain whether the severity of atherosclerotic disease differs in heterozygous FH caused by receptor-negative and receptor-defective mutations. The present authors investigated the influence of LDL receptor mutation type on the clinical phenotype in 31 patients with heterozygous FH caused by the receptor-negative, Trp23-stop mutation and in 31 patients heterozygous for the receptor defective Trp66-Gly mutation. Untreated levels of plasma LDL-cholesterol and calculated cholesterol-years score did not differ significantly between the two groups of patients. Detection of vascular disease was based on two approaches: (1) measurement of coronary calcification by spiral computed tomography (CT) scanning; and (2) ultrasonic measurement of carotid intima-media thickness (IMT). Age was significantly correlated to the presence of coronary calcification, but controlling for relevant cofactors, there was no evidence that the receptor-negative mutation caused more calcification than the receptor-defective mutation. Furthermore, carotid IMT was significantly influenced by plasma concentrations of Lp(a) and triglycerides, as well as by age, sex and smoking status, but again, there was no statistically significant effect of LDL receptor gene mutational type. The similarity in vascular phenotypes was probably caused by a similar life-long burden of LDL-cholesterol in the two groups of patients.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0009-9163
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
61
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
408-15
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:12121347-Adult,
pubmed-meshheading:12121347-Aged,
pubmed-meshheading:12121347-Arteriosclerosis,
pubmed-meshheading:12121347-Carotid Artery Diseases,
pubmed-meshheading:12121347-Codon, Terminator,
pubmed-meshheading:12121347-Family Health,
pubmed-meshheading:12121347-Female,
pubmed-meshheading:12121347-Genetic Testing,
pubmed-meshheading:12121347-Genotype,
pubmed-meshheading:12121347-Heterozygote,
pubmed-meshheading:12121347-Humans,
pubmed-meshheading:12121347-Hyperlipoproteinemia Type I,
pubmed-meshheading:12121347-Male,
pubmed-meshheading:12121347-Middle Aged,
pubmed-meshheading:12121347-Mutation,
pubmed-meshheading:12121347-Mutation, Missense,
pubmed-meshheading:12121347-Phenotype,
pubmed-meshheading:12121347-Receptors, LDL,
pubmed-meshheading:12121347-Risk Factors,
pubmed-meshheading:12121347-Vascular Diseases
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia.
|
| pubmed:affiliation |
Department of Internal Medicine and Cardiology, Aarhus Amtssygehus University Hospital, Aarhus, Denmark. jubp@post3.tele.dk
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|